What is it about?
The paper is about creating a medicine-like profile for biologic drug candidates. By analyzing the sequence and structural features of marketed biotherapeutics we constructed a profile that can be used to prioritize medicine-like candidates during drug discovery and development.
Featured Image
Why is it important?
This is important because drug discovery and development is hard work, time consuming, and risky business.
Read the Original
This page is a summary of: Intrinsic physicochemical profile of marketed antibody-based biotherapeutics, Proceedings of the National Academy of Sciences, September 2021, Proceedings of the National Academy of Sciences,
DOI: 10.1073/pnas.2020577118.
You can read the full text:
Contributors
The following have contributed to this page
